Literature DB >> 21406613

Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.

Stephen Welle1, Sangeeta Mehta, Kerri Burgess.   

Abstract

It is unclear whether the muscle hypertrophy induced by loss of myostatin signaling in mature muscles is maintained only by increased protein synthesis or whether reduced proteolysis contributes. To address this issue, we depleted myostatin by activating Cre recombinase for 2 wk in mature mice in which Mstn exon 3 was flanked by loxP sequences. The rate of phenylalanine tracer incorporation into myofibrillar proteins was determined 2, 5, and 24 wk after Cre activation ended. At all of these time points, myostatin-deficient mice had increased gastrocnemius and quadriceps muscle mass (≥27%) and increased myofibrillar synthesis rate per gastrocnemius muscle (≥19%) but normal myofibrillar synthesis rates per myofibrillar mass or RNA mass. Mean fractional myofibrillar degradation rates (estimated from the difference between rate of synthesis and rate of change in myofibrillar mass) and muscle concentrations of free 3-methylhistidine (from actin and myosin degradation) were unaffected by myostatin knockout. Overnight food deprivation reduced myofibrillar synthesis and ribosomal protein S6 phosphorylation and increased concentrations of 3-methylhistidine, muscle RING finger-1 mRNA, and atrogin-1 mRNA. Myostatin depletion did not affect these responses to food deprivation. These data indicate that maintenance of the muscle hypertrophy caused by loss of myostatin is mediated by increased protein synthesis per muscle fiber rather than suppression of proteolysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406613      PMCID: PMC3118593          DOI: 10.1152/ajpendo.00509.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  46 in total

1.  Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.

Authors:  Craig McFarlane; Erin Plummer; Mark Thomas; Alex Hennebry; Murray Ashby; Nicholas Ling; Heather Smith; Mridula Sharma; Ravi Kambadur
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

2.  Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice.

Authors:  Kirkwood E Personius; Aditi Jayaram; David Krull; Roger Brown; Tianshun Xu; Bajin Han; Kerri Burgess; Christopher Storey; Bharati Shah; Rabi Tawil; Stephen Welle
Journal:  J Appl Physiol (1985)       Date:  2010-07-01

3.  Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice.

Authors:  David L Allen; Allison S Cleary; Sarah F Lindsay; Amanda S Loh; Jason M Reed
Journal:  J Appl Physiol (1985)       Date:  2010-07-01

Review 4.  Skeletal muscle hypertrophy and atrophy signaling pathways.

Authors:  David J Glass
Journal:  Int J Biochem Cell Biol       Date:  2005-10       Impact factor: 5.085

5.  Myofibrillar protein synthesis in myostatin-deficient mice.

Authors:  Stephen Welle; Kirti Bhatt; Carl A Pinkert
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-11       Impact factor: 4.310

6.  Muscle growth after postdevelopmental myostatin gene knockout.

Authors:  Stephen Welle; Kirti Bhatt; Carl A Pinkert; Rabi Tawil; Charles A Thornton
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-12-05       Impact factor: 4.310

7.  Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.

Authors:  H Gilson; O Schakman; L Combaret; P Lause; L Grobet; D Attaix; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2006-10-12       Impact factor: 4.736

8.  Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy.

Authors:  Carissa A Steelman; Justin C Recknor; Dan Nettleton; James M Reecy
Journal:  FASEB J       Date:  2006-01-19       Impact factor: 5.191

9.  The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle.

Authors:  Brian A Clarke; Doreen Drujan; Monte S Willis; Leon O Murphy; Richard A Corpina; Elena Burova; Sergey V Rakhilin; Trevor N Stitt; Cam Patterson; Esther Latres; David J Glass
Journal:  Cell Metab       Date:  2007-11       Impact factor: 27.287

10.  Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.

Authors:  Stefan Girgenrath; Kening Song; Lisa-Anne Whittemore
Journal:  Muscle Nerve       Date:  2005-01       Impact factor: 3.217

View more
  8 in total

1.  Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.

Authors:  Sarah A Reed; Pooja B Sandesara; Sarah M Senf; Andrew R Judge
Journal:  FASEB J       Date:  2011-11-18       Impact factor: 5.191

2.  Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.

Authors:  Craig A Goodman; Rachel M McNally; F Michael Hoffmann; Troy A Hornberger
Journal:  Mol Endocrinol       Date:  2013-09-03

Review 3.  Androgen-mediated regulation of skeletal muscle protein balance.

Authors:  Michael L Rossetti; Jennifer L Steiner; Bradley S Gordon
Journal:  Mol Cell Endocrinol       Date:  2017-02-22       Impact factor: 4.102

Review 4.  Metabolic functions of glucocorticoid receptor in skeletal muscle.

Authors:  Taiyi Kuo; Charles A Harris; Jen-Chywan Wang
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

Review 5.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

Review 6.  New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass.

Authors:  Craig A Goodman; Troy A Hornberger
Journal:  F1000Prime Rep       Date:  2014-04-01

Review 7.  Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders.

Authors:  Rosamund C Smith; Boris K Lin
Journal:  Curr Opin Support Palliat Care       Date:  2013-12       Impact factor: 2.302

Review 8.  Role of microRNAs in skeletal muscle hypertrophy.

Authors:  Keisuke Hitachi; Kunihiro Tsuchida
Journal:  Front Physiol       Date:  2014-01-16       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.